115 Hexylaminolevulinate and Aminolevulinic acid Nanoemulsion have Similar Tolerability, Initial Efficacy and Cosmetic Outcome as Methylaminolevulinate in Photodynamic Therapy of Basal Cell Carcinoma in a Prospective Randomized Double-blinded Trial
Mari Salmivuori(Tampere University Hospital), Noora Neittaanmäki(University of Helsinki), Tadaaki Tani(Tokyo University of Agriculture and Technology), Leevi Annala(University of Jyväskylä), Janne Räsänen(Tampere University Hospital), M Grönroos(Päijät-Hämeen Keskussairaala), Erna Snellman(Tampere University Hospital), Ilkka Pölönen(University of Jyväskylä)
Cited by 4
Related Papers
A clinical benchmark of public self-supervised pathology foundation models
|Nature Communications|2025|93
Daylight photodynamic therapy for actinic keratoses: a randomized double‐blinded nonsponsored prospective study comparing 5‐aminolaevulinic acid nanoemulsion ( <scp>BF</scp> ‐200) with methyl‐5‐aminolaevulinate
|British Journal of Dermatology|2014|76
Attitudes Toward Artificial Intelligence Within Dermatopathology: An International Online Survey
|Frontiers in Medicine|2020|51
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection
|Nature Medicine|2025|50
Miniaturized hyperspectral imager calibration and UAV flight campaigns
|Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE|2013|47